Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.
Matakidou
A
A
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Mutsvangwa
K
K
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Ansell
W
W
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Lim
L
L
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Powles
T B
TB
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Oliver
R T
RT
Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
Shamash
J
J
Department of Medical Oncology, St Bartholomew's Hospital, London, UK. Electronic address: Jonathan.Shamash@bartsandthelondon.nhs.uk.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D016190:Carboplatin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D012074:Remission Induction; D018239:Seminoma / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D016190:Carboplatin